73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e
Patients with brain cancer may benefit from treatment to boost white blood cells

Patients with brain cancer may benefit from treatment to boost white blood cells

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisRadiation-induced lymphopenia correlated with decreased survival in patients with GBM. (A) The consort flow diagram

Patients with brain cancer may benefit from treatment to boost white blood cells

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisRadiation-induced lymphopenia correlated with decreased survival in patients with GBM. (A) The consort flow diagram
The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

by Lund UniversityDifferent types of fibroblasts in breast tumour tissue. Credit: Chris MadsenIn certain forms of cancer, connective tissue forms around and within the tumour. One previously unpr

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

by Lund UniversityDifferent types of fibroblasts in breast tumour tissue. Credit: Chris MadsenIn certain forms of cancer, connective tissue forms around and within the tumour. One previously unpr
Immunotherapy comparable to chemo for some advanced stomach cancers

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food
AI-guided personalized drug combinations to treat relapsed lymphoma

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q
Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

by SPIEMicroscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The

Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

by SPIEMicroscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The
Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on
In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

by University of Massachusetts AmherstTreatment approaches for breast cancer dormancy. Plausible therapeutic pathway targets to (A) directly kill, (B) maintain, or (C) activate and then kill dorm

In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

by University of Massachusetts AmherstTreatment approaches for breast cancer dormancy. Plausible therapeutic pathway targets to (A) directly kill, (B) maintain, or (C) activate and then kill dorm
Deadly cancers show early, detectable differences from benign tumors

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n
New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study
Blood cancer manipulates immune cells in order to survive, study shows

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce
Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance

Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance